Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System
Published on: March 17, 2023
Visual Acuity Outcomes Following Intravitreal Biological Drug-Induced Retinal Vasculitis: An Intelligent Research in
Isabella Tunon-Robinson1, Runzhi Zhang2, Ashley K Nguyen3
1School of Computing and Augmented Intelligence, Arizona State University, Tempe, Arizona, USA.
Intravitreal biological drugs may be linked to retinal vasculitis (RV), significantly increasing vision loss and legal blindness. Further research is needed to confirm this association and improve treatment safety.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Background:
- Retinal vasculitis (RV) is a serious condition affecting vision.
- Intravitreal (IVT) biological drugs are increasingly used for retinal diseases.
- Understanding the potential risks of IVT therapies is crucial for patient safety.
Purpose of the Study:
- To investigate visual acuity outcomes after retinal vasculitis (RV) events.
- To explore potential associations between IVT biological drugs and RV.
- To assess the real-world impact of RV on vision.
Main Methods:
- Retrospective analysis of a large ophthalmic registry.
- Included subjects receiving IVT anti-VEGF and anticomplement therapies.
- Excluded cases with multiple IVT biological drugs prior to RV diagnosis to isolate potential single-drug associations.
Main Results:
- Over 1.9 million subjects received IVT biological drugs; 2,115 diagnosed with RV.
- 436 subjects (531 eyes) had RV.
- RV diagnosis was associated with a 78% increase in legal blindness and a 46% increase in severe vision loss (counting fingers).
Conclusions:
- A substantial increase in legal blindness occurred post-RV diagnosis in real-world data.
- The association between biological therapy and RV requires cautious interpretation due to study limitations.
- Prospective studies are essential to confirm associations and enhance the safety of biological therapies for retinal conditions.
Related Concept Videos
Biological Influences on Intelligence
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Sight Distance in a Vertical Curve
Drug Products: Biologics, Biosimilars and Interchangeables
Intelligence
Predicting Reaction Outcomes

